The drive to inoculate India's billion-plus people against the deadly Covid-19 has brought to the fore concerns ranging from safety of the jabs to their equitable distribution as well as the manner and speed of the rollout.
Read MoreThe mass inoculation of the Indian population is expected to boost the growth momentum
Read MoreThe United States Food and Drug Administration (USFDA) has granted ODD to Saroglitazar Mg, Cadila Healthcare said in a regulatory filing.
Read MoreBharat Biotech performed the plaque reduction neutralisation test (PRNT50) using sera collected from the 26 recipients of Covaxin and tested them against the UK variant and heterologous strain
Read MoreThe new healthcare plan is likely to be unveiled on Feb. 1 when Finance Minister Nirmala Sitharaman presents the country's budget for 2020/21. The officials did not want to be named as the plan is not yet public
Read MoreThis is just a beginning and the home health care system has a lot to offer in future, say experts.
Read MorePhytopharmaceuticals is another huge opportunity for the pharma industry in India. To ensure viability and growth of the industry, there needs to be serious thought and incentives should be provided.
Read MoreOn the issue of data security, the home secretary wrote that the government is complying with the current best practices for ensuring cyber security.
Read More